…the discovery of autoimmune/inflammatory syndrome induced by adjuvants (ASIA), the work of leading researchers from 14 countries on the role of adjuvants in different vaccines and how they can induce diverse autoimmune clinical manifestations in genetically prone individuals has been published in the newly released medical textbook, Vaccines and Autoimmunity.
The textbook, which is intended for advanced students and researchers working in pathogenic and epidemiological studies…
…Contributors to Vaccines and Autoimmunity include clinical physicians and scientists at major universities and research hospitals in the United States, Canada, United Kingdom, Israel, Japan, Sweden, France, Italy, Spain, Greece, Brazil, Columbia, Mexico and Slovenia…
…It would seem that the true message of vaccine dangers and damage is finally bubbling to the surface.
We live in a time when the pharmaceutical industry (Big Pharma) appears to be losing some of its grip on past loyalties or purchased secrecy, and knowledge of this mechanism is becoming available even from sources we would not have expected a scant few years ago, the MSM and medical schools. These were bastions of absolute support for them in days gone by. It is my hope that we are in fact seeing an erosion of that very support…
My daughter Chiara is 13 years old. She was an athlete with a history of Hashimoto’s thyroiditis with elevated levels of anti-thyroid peroxidase antibodies. We discovered it much before receiving HPV vaccine.
I can tell you that she was a good athlete. Hashimoto’s did not stop her from participating in the World Championship Karate in Caorle twice. In 2010, she won the brown belt. Chiara’s other hobbies included painting, singing and practicing sports. That was before Gardasil.
Chiara’s story after Gardasil is as follows:
She received the first injection of the HPV vaccine Gardasil in March 2013. It was about ten days before her menstrual cycle. Afterward, she was sick for three days showing nausea, headache, stomach-ache and faint.
In April 2013 she was again sick for five days but the doctor said that could be just a strong menstrual syndrome.
In May 2013 she received the second shot and she was sick again for seven days.
During June 2013 she stayed sick for ten days.
By July 2013 she had an osteocondrite (a joint condition whereby a variable amount of bone and its adjacent cartilage loses its blood supply) at her astragalus (ankle) so she had to stop practicing sports. We contacted the gynecologist and she suggested to give her magnesium.
On September 2013 after the third shot, she started to have seriously strong stomachaches, like an acute allergic reaction. She did endoscopic exams, but all negative. She was treated with proton-pump inhibitors and she followed a diet without milk and derivatives, but no success.
In December 2013 she started to experience vasovagal syncope with strong stomachaches, headaches and insomnia.
During January 2014 she was kept in hospital for ten days, she repeated the endoscopic exam, and they found some eosinophil cells (eosinophilic esophagitis is an allergic inflammatory condition of the esophagus) and low levels of vitamin D.
During February 2014 she started to take vitamin D, B1, B6, B12, selenium. She started feeling better but, the heavy pain, insomnia and syncope episodes did not stop.
During the 2013-2014 school year, she missed more than 90 day of classroom for the above pains and symptoms.
In July 2014 the endocrinologist/gynecologist suspected endometriosis and decided to give her a contraceptive (Claire), but through NMR analysis everything appeared negative.
Although we brought Chiara to several medical doctors only one, a gynecologist, suggested that everything could be related to Gardasil treatments. All the others to which we talked about this idea treated us like mad people.
I have read several articles, but I am very impressed with one by Lloyd W. Phillip (Gardasil Syndrome). I think I have finally realized what happened my daughter.
At the moment she is taking selenium, magnesium, vitamin D, B1, B6, B12, melatonin and live lactic cultures. Although all the celiac tests were negative we discovered that celiac diet and low level of histamine related food seems to have some positive results.
The gynecologist changed her contraceptive with a stronger one to stop the menstrual cycle flow.
In the last month she is doing better, she had just one episode of syncope, less pain and the number of normal days have increased.
The syncope episodes seem to be related to her menstrual cycle, in particular the worse days are those overlapping with ovulation and menstruation days.
After two years she was finally able to go to school for two consecutive weeks. Before, she could not eat without vomiting, study or sleep. Meeting her friends for a day out was nearly impossible.
I wrote my daughter’s story to give you an idea about the injuries that Gardasil could cause. I hope our experience could help you decide to investigate before you decide to use an HPV vaccine.
Above all, I hope Chiara and all the other survivors of new medical conditions after HPV vaccinations find treatments to help them get their normal lives back.
Simona, thank you for sharing Chiara’s story. My heart aches that Chiara has been through so much. I am grateful she has your support.
I am sure others will prevent such experiences through your kindness in sharing this story.
I am happy to hear that Chiara has a physician that understands the issue. Here are also additional physicians that are great to work with and that have knowledge with treating these types of symptoms.Featured Doctors
You are in good care withSaneVax. They have excellent practitioners that they work with as well. They have big hearts and are experts in this area.
I know that as you surround yourselves with those that understand and have the capacity to assist you, that your circumstances will improve.
Stay close to God. He loves you and is fully aware of your situation. He will guide you all along the way as you draw near to him. You are in my prayers and thoughts.
Here is a little musical piece that I hope you enjoy. It’s really popular in the States right now.
Attorney Monica Leon Del Rio is currently representing several Colombian girls who are experiencing new medical conditions after the administration of Gardasil. She recently invited me to speak to a group of esteemed public health officials, government representatives and medical people in Colombia to explain why the SaneVax team does not support HPV vaccination programs.Just prior to the time I was to address the meeting, the international conference call was disconnected. Despite multiple attempts to re-establish the connection I was not able to speak as scheduled.
Therefore, my intended message to Colombia is as follows:
SaneVax is an international non-profit organization working with representatives in over 25 countries, all of whom are concerned about HPV vaccines. The SaneVax team believes vaccines should meet four common sense criteria prior to their inclusion in mass vaccination programs. We believe they should be scientifically proven safe, affordable, necessary and effective prior to government approval.
The SaneVax Team cannot support HPV vaccination programs for many reasons.
#1 HPV VACCINES ARE NOT PROVEN SAFE
There are over 80 vaccines approved for use in the United States. HPV vaccines account for nearly 25% of the entire Vaccine Adverse Event Reporting System (VAERS) database. This is particularly disturbing because the VAERS system was established in 1990 and HPV vaccines were not introduced until mid-2006.
VAERS reports of ADEM have increased over 1,000% since the introduction of HPV vaccines; infertility reports increased 790%, reports of blindness increased 188%, and spontaneous abortions by 270%.
According to documents submitted to the Supreme Court in India, when 24,000 girls were injected with HPV vaccines during ‘demonstration projects’ an estimated 5% (1200) were left with chronic health problems and/or autoimmune disorders.
Japan withdrew the government recommendation for the administration of HPV vaccines after only 6 weeks when reports of adverse events after Gardasil were 26 times higher than the annual flu shot; reports after Cervarix were 52 times higher than the annual flu shot. 24.9% of the adverse events reported were considered serious.
Denmark reports that 24% of the adverse events reported after HPV vaccinations were considered serious.
Italy reports adverse events after HPV vaccines at a rate of 219/100,000 – ten times higher than most other vaccines administered in Italy. The cervical cancer rate in Italy is 7.7/100,000.
#2 HPV VACCINES ARE NOT AFFORDABLE
HPV vaccination programs do not eliminate the need for pap screening, they simply add the price of 3 injections to already overburdened healthcare systems around the globe.
There is an already proven safe and effective method of controlling cervical cancer in most developed countries – pap screening and good gynecological follow-up. Countries without this practice in place would be money ahead to spend their healthcare budget developing the infrastructure to provide this type of care.
Cervical cancer causes 2.3 deaths/100,000 women in the United States. The cost of 3 doses of HPV vaccine for 100,000 women is an estimated $30,000,000 ($100/dose) to try and eliminate less than 3 deaths which could have been avoided with pap screening and good gynecological follow-up. How many medical professionals could be trained and/or medical facilities built with that same 30 million dollars?
#3 HPV VACCINES ARE NOT NECESSARY
The human papillomavirus has never been proven to cause cancer by itself. Other risk factors must also be present in order to prompt the development of cancer.
According to the World Health Organization, only 0.15% of all people exposed to any high-risk strain of HPV will ever develop cervical cancer. The vast majority of HPV ‘infections’ are benign and cause no medical problem whatsoever.
HPV type prevalence varies greatly from one region to the next. Are the HPV types targeted by current vaccines the same ones prevalent in your country?
There is no excuse for exposing the female population of the world to the risks involved with HPV vaccination when there is an already proven safe, affordable, necessary and effective means of controlling cervical cancer.
#4 HPV VACCINES ARE NOT PROVEN EFFECTIVE
According to the World Health Organization, only 1% of CIN1 progresses to the next stage, only 1.5% of CIN2 progresses. Only 12% of CIN3 lesions, which are actually considered a pre-cursor to cancer. Nevertheless, the FDA allowed the manufacturers of HPV vaccines to use these often self-reversing abnormal lesions as endpoints to judge the efficacy of their products.
The other endpoint used to predict efficacy was antibody titers. No one has determined what level of antibodies is necessary to prevent HPV infections. It is simply assumed that the higher the antibody titer level, the better the potential protection.
HPV vaccines have not been clinically proven to prevent a single case of cancer.
There is no guarantee that eliminating one risk factor for the development of cervical cancer will have any impact on the disease incidence or mortality rate.
It will take more than 20 years to determine whether or not HPV vaccines perform as advertised.
There is no guarantee that any suppressed oncogenic HPV type will not mutate over the next 20 years and become more dangerous.
I would respectfully submit that all of these facts should be taken into consideration when evaluating the HPV vaccination program in Colombia.
Please consider every new medical condition following HPV vaccine administration to be a potential adverse event. Thorough investigations are the only way to determine the safety profile of HPV vaccines in your country.
Please take action to protect your future generation.
Halt the current HPV vaccination program until you have determined whether or not HPV vaccines are a good addition to your cervical cancer prevention program.
You must answer the question – Are HPV vaccines Safe, Affordable, Necessary and Effective in Colombia?
La abogada Mónica León Del Rio actualmente representa a varias niñas colombianas que están experimentando nuevas afecciones médicas después de la administración de Gardasil. Ella hace poco me invitó a hablar a un grupo de funcionarios de salud pública, representantes gubernamentales y personal médico en Colombia para explicar por qué el equipo SaneVax no respalda los programas de vacunación contra el VPH.Justo antes de mi participación en la conferencia internacional, se desconectó la llamada. A pesar de múltiples intentos para restablecer la conexión no pude hacer mi presentación.
Por lo tanto, mi mensaje destinado a Colombia es el siguiente:
SaneVax es una organización internacional sin ánimo de lucro que trabaja con representantes en más de 25 países, todos los cuales están preocupados acerca de las vacunas contra el VPH. El equipo SaneVax cree que las vacunas deben cumplir con 4 criterios de sentido común antes de incluirse en los programas de vacunación masiva. Creemos que deben ser demostrados científicamente que son seguras, asequibles, necesarias y eficaces antes de ser aprobadas por el gobierno.
El Equipo SaneVax no puede apoyar los programas de vacunación contra el VPH por muchas razones.
#1 No se ha demostrado que las vacunas contra el VPH sean SEGURAS
Hay más de 80 vacunas aprobadas para su uso en los Estados Unidos. Las vacunas contra el VPH representan casi el 25% de toda la base de datos de Eventos Adversos de Vacunas (VAERS). Esto es especialmente preocupante porque el sistema VAERS se estableció en 1990 y vacunas contra el VPH no se introdujeron hasta mediados de 2006.
VAERS informa que los casos de Encefalitis Aguda Diseminada se han incrementado en un 1.000% desde la introducción de vacunas contra el VPH; los informes de infertilidad se incrementaron 790%, los casos de ceguera aumentaron 188%, y los abortos espontáneos por 270%.
De acuerdo con los documentos presentados a la Corte Suprema de la India, cuando 24.000 niñas fueron inyectadas con vacunas contra el VPH durante los “proyectos de demostración”, se estima que un 5% (1.200) quedaron con problemas de salud crónicos y / o trastornos autoinmunes.
Japón retiró la recomendación del gobierno para la administración de las vacunas contra el VPH después de sólo 6 semanas, cuando los informes de eventos adversos después de la aplicación del Gardasil eran 26 veces más altos que los de la vacuna anual contra la gripe; los informes de eventos adversos después de la aplicación de Cervarix fueron 52 veces más altos que los de la vacuna anual contra la gripe. El 24,9% de los eventos adversos informados fueron considerados graves.
Dinamarca informa que se consideran graves un 24% de los eventos adversos informados después de la vacunación contra el VPH.
Italia informa de los eventos adversos después de la aplicación de las vacunas contra el VPH a una tasa del 219/100 000 – diez veces más alta que la mayoría de las vacunas administradas en Italia. La tasa de cáncer de cuello uterino en Italia es de 7,7 / 100.000.
#2 Las vacunas contra el VPH NO SON ADSEQUIBLES
Los programas de vacunación contra el VPH no eliminan la necesidad de las pruebas de detección de Papanicolaou (citología vaginal), inclusive hay que añadir el precio de 3 inyecciones que se sobrecargan a los sistemas sanitarios de todo el mundo.
La detección mediante la prueba de citología vagina (prueba de Papanicolaou) es un método seguro y eficaz ya probado para controlar el cáncer cervical en los países más desarrollados incluyendo el buen seguimiento ginecológico.
El cáncer cervical provoca 2,3 muertes / 100.000 mujeres en los Estados Unidos. El costo de 3 dosis de la vacuna contra el VPH para 100.000 mujeres tiene un costo estimado de $ 30.000.000 ($ 100 / dosis) para tratar de eliminar menos de 3 muertes que podrían haberse evitado con la prueba de Papanicolaou y un buen seguimiento ginecológico. ¿Cuántos profesionales de la medicina podrían ser capacitados o cuántas instalaciones médicas se podrían construir con los mismos 30 millones de dólares?
#3 Las vacunas contra el VPH no son necesarias
El virus del papiloma humano nunca se ha demostrado que cause el cáncer por sí mismo. Otros factores de riesgo también deben estar presentes para facilitar el desarrollo del cáncer.
De acuerdo con la Organización Mundial de la Salud, sólo el 0,15% de todas las personas expuestas a cualquier cepa de alto riesgo de VPH desarrollarán cáncer cervical. La gran mayoría de los ”infecciones” por VPH son benignas y no causan ningún problema médico.
La prevalencia del tipo de VPH varía mucho de una región a otra. ¿Son los tipos de VPH que son el blanco de las vacunas actuales los mismos que prevalecen en su país?
No hay excusa para la exposición de la población femenina del mundo a los riesgos que implica la vacunación contra el VPH cuando ya hay métodos seguros, asequibles, necesarios y efectivos probados para el control del cáncer cervical.
#4 Las vacunas contra el VPH no tienen una eficacia demostrada
De acuerdo con la Organización Mundial de la Salud, sólo el 1% de Neoplasia Intraepitelial Cervical 1 (CIN1) avanza a la siguiente etapa CIN2 y de esta sólo el 1,5% progresa. Solo un 12% de las lesiones CIN3 son en verdad consideradas como precursoras del cáncer. Sin embargo, la FDA permitió a los fabricantes de vacunas contra el VPH utilizar estas lesiones anormales que a menudo se curan por sí mismas como criterios para juzgar la eficacia de la vacuna.
El otro criterio de valoración utilizado para predecir la eficacia fueron las medidas de anticuerpos. Nadie ha determinado cuál es el nivel de anticuerpos necesario para prevenir las infecciones por VPH. Simplemente se supone que el nivel más alto de anticuerpos es potencialmente mejor.
No se ha demostrado clínicamente que ninguna vacuna contra el VPH prevenga un solo caso de cáncer.
No hay garantía de que la eliminación de un factor de riesgo para el desarrollo de cáncer de cuello uterino (infección por VPH) tendrá impactos sobre la incidencia de la enfermedad o tasa de mortalidad.
Tardará más de 20 años para determinarse si las vacunas contra el VPH funcionan o no como se anuncia.
No hay garantía de que cualquier tipo de VPH oncogénico suprimido por la vacuna no va a mutar en los próximos 20 años y ser más peligroso.
Me permito pedir respetuosamente que todos estos hechos sean tenidos en cuenta al evaluar el programa de vacunación contra el VPH en Colombia.
Por favor consideren que cada nuevo caso de anormalidad médica luego de la administración de la vacuna contra el VPH puede ser un evento adverso a la misma. Las investigaciones exhaustivas son la única manera de determinar el perfil de seguridad de las vacunas contra el VPH en su país.
Por favor, tomen medidas para proteger sus generaciones futuras.
Detengan el programa de vacunación contra el VPH actual hasta que se haya determinado si las vacunas contra el VPH son una buena adición al programa de prevención de cáncer de cuello uterino.
Deben responder a la pregunta – ¿Son las vacunas contra el VPH seguras, asequibles, necesarias y eficaces en Colombia?
